| |
| |
|
| Insider
Information: |
Katz Richard D |
| Relationship: |
Chief Financial Officer |
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
20,530 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$131,165 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
20,530 |
|
|
| Total
Value |
$131,165 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Icagen Inc |
ICGN |
Ex VP, Fin & Corp, CFO... |
2011-09-14 |
0 |
2006-02-01 |
0 |
Premium* |
|
|
Argos Therapeutics Inc |
ARGS |
Vice President and CFO |
2018-04-25 |
9,697 |
2017-01-19 |
0 |
Premium* |
|
|
Liquidia Technologies Inc |
LQDA |
Chief Financial Officer |
2020-03-18 |
10,833 |
2020-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LQDA |
Liquidia Technologies Inc |
Chief Financial Officer |
• – – |
2020-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,833 |
10,833 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
Vice President and CFO |
• – – |
2018-04-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(22,629) |
9,697 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
Vice President and CFO |
• – – |
2018-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
22,629 |
32,326 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
Vice President and CFO |
• – – |
2018-01-10 |
4/A |
AS |
$0.16 |
$17,200 |
D/D |
(104,435) |
193,959 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
Vice President and CFO |
• – – |
2018-01-09 |
4 |
AS |
$0.16 |
$17,200 |
D/D |
(104,435) |
193,959 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
Vice President and CFO |
• – – |
2018-01-03 |
4 |
AS |
$0.16 |
$16,541 |
D/D |
(101,228) |
298,394 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2017-08-30 |
4 |
A |
$0.00 |
$0 |
D/D |
395,664 |
399,622 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
VP & Chief Financial Officer |
• – – |
2017-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,958 |
3,958 |
0 |
- |
|
| ICGN |
Icagen Inc |
Ex VP, Fin & Corp, CFO & Treas |
• – – |
2011-09-14 |
4 |
D |
$6.00 |
$203,412 |
D/D |
(33,902) |
0 |
0 |
- |
|
| ICGN |
Icagen Inc |
Ex VP, Fin & Corp, CFO & Treas |
• – – |
2011-09-09 |
4 |
D |
$6.00 |
$102,216 |
D/D |
(17,036) |
33,902 |
0 |
- |
|
| ICGN |
Icagen Inc |
Ex VP, Fin & Corp, CFO & Treas |
• – – |
2011-09-02 |
4 |
D |
$6.00 |
$150,204 |
D/D |
(25,034) |
50,938 |
0 |
- |
|
| ICGN |
Icagen Inc |
Ex VP, Fin & Corp, CFO & Treas |
• – – |
2011-08-18 |
4 |
S |
$5.96 |
$48 |
D/D |
(8) |
75,972 |
0 |
- |
|
| ICGN |
Icagen Inc |
Ex VP, Fin & Corp, CFO & Treas |
• – – |
2011-08-18 |
4 |
D |
$5.96 |
$5,012 |
D/D |
(841) |
75,980 |
0 |
- |
|
| ICGN |
Icagen Inc |
Ex VP, Fin & Corp, CFO & Treas |
• – – |
2011-08-17 |
4 |
D |
$6.00 |
$1,410 |
D/D |
(235) |
76,821 |
0 |
- |
|
| ICGN |
Icagen Inc |
Ex VP, Fin & Corp, CFO & Treas |
• – – |
2011-08-10 |
4 |
D |
$5.96 |
$24,919 |
D/D |
(4,181) |
77,092 |
0 |
- |
|
| ICGN |
Icagen Inc |
Ex VP, Fin & Corp, CFO & Treas |
• – – |
2011-08-10 |
4 |
S |
$5.96 |
$215 |
D/D |
(36) |
77,056 |
0 |
- |
|
| ICGN |
Icagen Inc |
Ex VP, Fin & Corp, CFO & Treas |
• – – |
2011-05-25 |
4 |
D |
$2.48 |
$2,118 |
D/D |
(854) |
81,273 |
0 |
- |
|
| ICGN |
Icagen Inc |
Ex VP, Fin & Corp, CFO & Treas |
• – – |
2011-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
82,127 |
0 |
- |
|
| ICGN |
Icagen Inc |
Ex VP, Fin & Corp, CFO & Treas |
• – – |
2011-02-01 |
4 |
D |
$3.41 |
$1,282 |
D/D |
(376) |
32,127 |
0 |
- |
|
| ICGN |
Icagen Inc |
Ex VP, Fin & Corp, CFO & Treas |
• – – |
2011-01-29 |
4 |
D |
$2.94 |
$1,038 |
D/D |
(353) |
32,503 |
0 |
- |
|
| ICGN |
Icagen Inc |
Ex VP, Fin & Corp, CFO & Treas |
• – – |
2011-01-23 |
4 |
D |
$2.49 |
$6,170 |
D/D |
(2,478) |
32,856 |
0 |
- |
|
| ICGN |
Icagen Inc |
Ex VP, Fin & Corp, CFO & Treas |
• – – |
2011-01-12 |
4 |
D |
$1.93 |
$239 |
D/D |
(124) |
35,334 |
0 |
- |
|
| ICGN |
Icagen Inc |
Sr VP, Fin & Corp, CFO & Treas |
• – – |
2010-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
283,658 |
0 |
- |
|
| ICGN |
Icagen Inc |
Ex VP, Fin & Corp, CFO & Treas |
• – – |
2010-02-01 |
4 |
D |
$0.89 |
$2,823 |
D/D |
(3,172) |
243,658 |
0 |
- |
|
| ICGN |
Icagen Inc |
Ex VP, Fin & Corp, CFO & Treas |
• – – |
2010-01-29 |
4 |
D |
$0.86 |
$2,557 |
D/D |
(2,973) |
246,830 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
